Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-29

Clinical Trial Update: Oracea Soolantra Association in Participants With Severe Rosacea [Phase 4]

View source ↗

Summary

Phase 4 trial exploring the association of Oracea and Soolantra in participants with severe rosacea has completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ORACEA (Doxycycline)
  • Soolantra (ivermectin)

Snippet

Sponsor: Galderma R&D | Conditions: Rosacea | Phase 4 | Status: COMPLETED | Results posted: 2019-11-29